Pralym®

Pralatrexate

Product Information

  • Proprietary Name: Pralym®
  • Generic Name: Pralatrexate
  • Dosage Form: Vial
  • Strengths: 20 mg/1 ml
  • Indications: Peripheral T-cell Lymphoma (PTCL)

Oncology

Pralym®

Pralatrexate is indicated for the treatment of peripheral T-cell lymphoma (PTCL).

Ready to get started?

Curious about a specific position? Sign up for it.
© NanoAlvand. All rights reserved. Powered by ِDGN.